Inventor
DE DIEGO HEIDI LOPEZ
DK17 patents
⚠️ This page may combine multiple inventors who share the name “DE DIEGO HEIDI LOPEZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
9 patentsUS11130775B2Sep 28, 2021
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS14 citations92
US11858954B2Jan 2, 2024
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS8 citations83
US12421271B2Sep 23, 2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS0 citations61
US11279682B2Mar 22, 2022
Vortioxetine pyroglutamate
H LUNDBECK AS0 citations57
US10857149B2Dec 8, 2020
Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine
H LUNDBECK AS0 citations51
US9938286B2Apr 10, 2018
Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption
H LUNDBECK AS0 citations51
US9725458B2Aug 8, 2017
Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption
H LUNDBECK AS0 citations51
US10287261B2May 14, 2019
Vortioxetine pyroglutamate
H LUNDBECK AS0 citations46
US10071963B2Sep 11, 2018
Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of Alzheimer's disease
H LUNDBECK AS0 citations46
LUNDBECK & CO AS H
5 patentsUS8969355B2Mar 3, 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
LUNDBECK & CO AS H15 citations92
US7648991B2Jan 19, 2010
Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
LUNDBECK & CO AS H29 citations92
US9227946B2Jan 5, 2016
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
LUNDBECK & CO AS H9 citations91
US9125909B2Sep 8, 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
LUNDBECK & CO AS H9 citations91
US9125908B2Sep 8, 2015
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
LUNDBECK & CO AS H11 citations91